-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Focus on the Two Sessions of the City: Strengthen Hierarchical Medical Care and Support the Construction of “Healthy Shijiazhuang”
Category:
Time：2018-02-10
Committee Member Han Shuqin suggested how to leverage medical consortia as a key driver to effectively implement the tiered diagnosis and treatment system, mobilize the enthusiasm of medical resources at all levels, and alleviate the widespread public concern over the difficulties and high costs of accessing healthcare. During the joint discussion at the second session of the 13th Municipal Committee of the Chinese People's Political Consultative Conference in Shijiazhuang on February 6, Han Shuqin, a municipal CPPCC member and deputy general manager of a company, offered suggestions on strengthening the tiered diagnosis and treatment system, invigorating medical resources at all levels, and advancing the construction of “Healthy Shijiazhuang.” “As healthcare reform enters the ‘deep waters,’ the situation where large medical institutions are overcrowded while grassroots medical facilities remain sparsely attended has yet to be fundamentally improved,” she noted.
Committee Member Han Shuqin suggests:
On February 6, during the joint discussion at the second session of the 13th Municipal Committee of the Chinese People's Political Consultative Conference in Shijiazhuang, Han Shuqin, a member of the Municipal CPPCC and Deputy General Manager of the company, offered suggestions on how to strengthen tiered medical care, activate medical resources at all levels, and address the widespread public concern about the difficulties and high costs of accessing healthcare. She emphasized leveraging medical consortia as a key driver to effectively implement tiered diagnosis and treatment and promote the construction of “Healthy Shijiazhuang.”
“As healthcare reform enters the ‘deep waters,’ the situation—where large medical institutions are overcrowded while grassroots medical facilities remain sparsely attended—has yet to be fundamentally improved, and many challenges still remain to be addressed.”
“We must earnestly refine the institutional design for tiered diagnosis and treatment and medical insurance payment, taking into account the interests of all parties involved and clearly defining their respective responsibilities, so that tiered diagnosis and treatment can be effectively implemented without fragmentation,” suggested Committee Member Han Shuqin. She proposed strengthening policies aimed at building tightly integrated healthcare consortia, improving institutional designs for income distribution and cost management among these consortia, leveraging the regulatory role of medical insurance policies to appropriately widen price differentials among medical institutions at different levels, promptly and scientifically adjusting medical insurance system designs and reimbursement policies, enhancing the distinctions in reimbursement levels across tiers, establishing and perfecting policy guidance encouraging insured individuals to seek initial consultations at grassroots-level facilities, tilting resources toward grassroots medical institutions, and favoring patients referred according to established protocols, thereby promoting orderly medical care access for patients.
“By promoting tiered medical care and encouraging patients to stay at the primary-care level, primary-care medical institutions must be equipped with the capacity to effectively handle patient needs. The key lies in building a high-caliber team of primary-care healthcare professionals, streamlining talent mobility mechanisms, and creating more opportunities for young doctors’ personal development—ensuring that they can both stay and thrive at the primary-care level.”
“To ensure that tiered diagnosis and treatment truly deliver results, we must address the practical challenges currently facing this system—such as the lack of unified referral standards and effective oversight mechanisms—so that patients can both ‘move up’ when necessary and ‘move down’ when appropriate.” She believes that within medical consortia, it’s essential to establish smooth, two-way referral “green channels,” refine the criteria for such referrals, and set up corresponding assessment, reward-and-punishment, and oversight mechanisms, ensuring that medical institutions and doctors at all levels have clear guidelines to follow when promoting tiered diagnosis and treatment. She also suggests establishing an Internet-plus-based information support system for medical consortia, which would help bring more high-quality medical resources “downward” and truly harness the critical role of technology in tiered diagnosis and treatment.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license